These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11071022)

  • 1. De novo onset of Parkinson's disease after antidepressant treatment with citalopram.
    Stadtland C; Erfurth A; Arolt V
    Pharmacopsychiatry; 2000 Sep; 33(5):194-5. PubMed ID: 11071022
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Devos D; Dujardin K; Poirot I; Moreau C; Cottencin O; Thomas P; Destée A; Bordet R; Defebvre L
    Mov Disord; 2008 Apr; 23(6):850-7. PubMed ID: 18311826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Citalopram and desmethylcitalopram for psychiatric patients].
    Linnet K; Olesen OV
    Ugeskr Laeger; 1996 Aug; 158(35):4920-3. PubMed ID: 8801700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram therapy as a risk factor for symptomatic hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): a case report.
    Miehle K; Paschke R; Koch CA
    Pharmacopsychiatry; 2005 Jul; 38(4):181-2. PubMed ID: 16025423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Open preliminary study of new antidepressive compound: citalopram].
    Ropert R; Lôo H; Gay C
    Encephale; 1984; 10(3):131-4. PubMed ID: 6594229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL; Schmitt L; Bagheri H
    Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population.
    Ham BJ; Lee BC; Paik JW; Kang RH; Choi MJ; Choi IG; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):104-7. PubMed ID: 16979275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.
    Bech P; Tanghøj P; Andersen HF; Overø K
    Psychopharmacology (Berl); 2002 Aug; 163(1):20-5. PubMed ID: 12185396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Depressive disorders in patients after stroke].
    Gusev EI; Bogolepova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 22():10-5. PubMed ID: 19431241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life measurement in antidepressant trials. Is there an added value?
    De Fruyt J; Demyttenaere K
    Psychother Psychosom; 2009; 78(4):212-9. PubMed ID: 19401621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent hyponatremia associated with citalopram and mirtazapine.
    Bavbek N; Kargili A; Akcay A; Kaya A
    Am J Kidney Dis; 2006 Oct; 48(4):e61-2. PubMed ID: 16997047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citalopram-associated clitoral priapism: a case series.
    Berk M; Acton M
    Int Clin Psychopharmacol; 1997 Mar; 12(2):121-2. PubMed ID: 9219048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does fluoxetine exacerbate Parkinson's disease?
    Caley CF; Friedman JH
    J Clin Psychiatry; 1992 Aug; 53(8):278-82. PubMed ID: 1500404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype.
    Haffen E; Vandel P; Broly F; Vandel S; Sechter D; Bizouard P; Bechtel PR
    Pharmacopsychiatry; 1999 Nov; 32(6):232-4. PubMed ID: 10599932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of tardive and L-dopa-induced dyskinesias to antidepressants.
    el-Awar M; Freedman M; Seeman P; Goldenberg L; Little J; Solomon P
    Can J Neurol Sci; 1987 Nov; 14(4):629-31. PubMed ID: 3690436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can chemotherapy induce reactions of recollection?
    Granet R; Sutter S
    Psychooncology; 2007 Nov; 16(11):1053. PubMed ID: 18038448
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug treatment of frequent disorders in patients with Parkinson's disease].
    Martí Massó JF; Poza JJ; López de Munain A
    Neurologia; 1996 Mar; 11(3):109-15. PubMed ID: 8695142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.
    Pasquini M; Biondi M; Costantini A; Cairoli F; Ferrarese G; Picardi A; Sternberg C
    Depress Anxiety; 2006; 23(7):441-8. PubMed ID: 16841345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.